|
|
Life Sciences Technology
|
|
Biotechnology & Pharmaceuticals
|
|
The collaboration of these two markets is continuing. Drug discovery, and its eventual development into viable therapeutics, is the goal of most early stage firms, as well as, large pharmaceutical companies. Leveraging business development relationships with large pharmaceutical companies can only enhance such goals and provide the patients with appropriate therapeutics in a timely manner at improving costs.
Companies that can provide the drug discovery tools and services necessary to improve the discovery and development process will be important to this continuum of product development. The consumer will benefit with improved technologies, as it will speed the time to market. Finding the talent to address the regulatory, operational and commercial aspects of this industry is our expertise.
Practice Leader:
John Baker - Boston
Consultants:
Carl Bretko - Philadelphia
Michael Carey - New York
Kim Chan - Singapore
Eric Dieny - Shanghai
Supriya Dikshit - Mumbai
Caroline Edwards - Hong Kong**
Victor Filamor - Hong Kong**
John R. Hamilton - Pittsburgh
Julie Kanak - Chicago***
Sussannah Kelly - Toronto
Dhanee Kieosangsong - Bangkok
Victor Kleinman - Palm Beach
Kelvin Ling - Hong Kong**
Carolyn Lowe - Philadelphia
James McFadzean - Silicon Valley
John McLean - Chicago***
Larry Munson - St. Louis
Mike Nagata - Tokyo
Mercedes Paz - Los Angeles
Bart Penfold - San Francisco
Scott Rabinowitz - Seattle
William Ross - Los Angeles
Shigemasa Saida - Tokyo
Johannes Suciu - Frankfurt
Dennis Taylor - St. Louis
Sherry Wang - Taipei
Jan Westerink - Amsterdam**
Lauren Lee White - Newark
Lance Winn - Austin
Dan Xie - Shanghai
Frederik van der Zeeuw - Amsterdam**
|
|